Stockscreener 앱 받기
21.94
3.94%
-0.90
시간 외 거래:
21.94
Ceribell Inc 주식(CBLL)의 최신 뉴스
FDA clearances: Siemens Healthineers, Medtronic, CeriBell - Modern Healthcare News
Risk Hedge: Does CeriBell Inc stock reflect fundamentalsJuly 2025 Levels & Daily Chart Pattern Signal Reports - baoquankhu1.vn
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion - Yahoo Finance
Growth Value: Does CeriBell Inc have consistent dividend growthAnalyst Downgrade & Real-Time Market Trend Scan - baoquankhu1.vn
Protara, Ceribell rise on FDA breakthrough designations - MSN
CBLL: FDA-cleared AI neuromonitoring expands to pediatrics and delirium, driving growth and efficiency - TradingView — Track All Markets
CBLL: 2026 growth will accelerate with new FDA clearances, VA expansion, and pediatric launches - TradingView — Track All Markets
Ceribell sues Natus Medical for patent infringement - MSN
CeriBell, Inc. (NASDAQ:CBLL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Ceribell shares advance after FDA grants breakthrough device status - MSN
CeriBell, Inc.'s (NASDAQ:CBLL) Shares May Have Run Too Fast Too Soon - simplywall.st
Is CeriBell Inc. stock a buy on dips2025 Top Decliners & Long-Term Safe Return Strategies - Улправда
Is CeriBell Inc. stock attractive for retirement portfoliosOptions Play & AI Driven Price Predictions - ulpravda.ru
Will CeriBell Inc. stock rally after Fed decisions2025 Key Highlights & Reliable Intraday Trade Plans - ulpravda.ru
Aug Technicals: Why CeriBell Inc. stock could outperform in 2025Portfolio Risk Summary & High Return Trade Opportunity Guides - ulpravda.ru
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 5,556 Shares - MarketBeat
Ceribell’s Foehr sells $125k in shares after option exercise By Investing.com - Investing.com Nigeria
Xingjuan Chao Sells 79,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell CEO Chao Xingjuan sells $1.68 million in shares By Investing.com - Investing.com South Africa
Ceribell CEO Chao Xingjuan sells $1.68 million in shares - Investing.com
Pittsburgh Post-GazetteCeriBell, Inc.Common Stock (Nasdaq:CBLL) Detailed Stock Data - FinancialContent
Will CeriBell Inc. stock benefit from infrastructure spendingFootwear buying guidance for recovery days and low impact training focuses on balanced cushioning and support, making it a solid option for daily use. - ulpravda.ru
Ceribell director resigns to pursue other professional ventures - MSN
Ceribell Gets FDA Breakthrough Device Status - Medical Device and Diagnostic industry
Ceribell’s AI Stroke Detection Tool Gains FDA Breakthrough Status - Zenopa
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection - Yahoo Finance
FDA grants breakthrough designation for Ceribell’s stroke detection monitor By Investing.com - Investing.com Nigeria
Ceribell receives FDA breakthrough device designation for LVO SD monitor - TipRanks
CeriBell (NASDAQ:CBLL) Hits New 12-Month HighHere's Why - MarketBeat
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool - TipRanks
Ceribell, Inc. Receives FDA Breakthrough Device Designation for LVO Stroke Solution - TradingView — Track All Markets
Protara, CeriBell rise on FDA breakthrough designations (TARA:NASDAQ) - Seeking Alpha
Ceribell receives FDA breakthrough device designation for LVO stroke detection - marketscreener.com
Ceribell’s LVO Stroke Detection Monitor Wins FDA Breakthrough Nod - Medical Product Outsourcing
CeriBell stock climbs after FDA Breakthrough Device Designation By Investing.com - Investing.com Nigeria
FDA grants breakthrough designation for Ceribell’s stroke detection monitor - Investing.com India
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution - marketscreener.com
Ceribell director Lucian Iancovici resigns from board and committees By Investing.com - Investing.com Nigeria
Ceribell director Lucian Iancovici resigns from board and committees - Investing.com
Ceribell, Inc. Announces Board Resignation - TradingView — Track All Markets
CeriBell, Inc. Announces Resignation of Lucian Iancovici as Chair of the Nominating and Corporate Governance Committee and as Member of the Compensation Committee, Effective as of December 31, 2025 - marketscreener.com
CeriBell stock climbs after FDA Breakthrough Device Designation - Investing.com
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
0.42%
1.96%
자본화:
|
볼륨(24시간):